Center for Liver Disease and Transplantation

A Commitment to Research

Physicians and academic researchers at the Center for Liver Disease and Transplantation share a deep commitment to clinical innovation. Many of the Center's studies address hepatitis C, which is the leading indication for transplantation and a major cause of organ failure after transplantation.

NewYork-Presbyterian Hospital investigators have participated in virtually every clinical trial of new hepatitis C drugs which have revolutionized the treatment of this infection and increase the likelihood of cure.